These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24421238)

  • 1. [Study of Parkinson's disease based on Drosophila model].
    Liang J; Luo J; Jin J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 Nov; 42(6):685-92. PubMed ID: 24421238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathology of familial Parkinson's disease].
    Wakabayashi K; Takahashi H
    Brain Nerve; 2007 Aug; 59(8):851-64. PubMed ID: 17713121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Astrocytes in Parkinson's Disease Associated with Genetic Mutations and Neurotoxicants.
    Kim S; Pajarillo E; Nyarko-Danquah I; Aschner M; Lee E
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Animal models for familial Parkinson's disease].
    Takahashi R
    Rinsho Shinkeigaku; 2007 Nov; 47(11):938-40. PubMed ID: 18210841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin.
    Clark IE; Dodson MW; Jiang C; Cao JH; Huh JR; Seol JH; Yoo SJ; Hay BA; Guo M
    Nature; 2006 Jun; 441(7097):1162-6. PubMed ID: 16672981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PINK1-Parkin signaling in Parkinson's disease: Lessons from Drosophila.
    Imai Y
    Neurosci Res; 2020 Oct; 159():40-46. PubMed ID: 32035987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic animal models of Parkinson's disease.
    Dawson TM; Ko HS; Dawson VL
    Neuron; 2010 Jun; 66(5):646-61. PubMed ID: 20547124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What have we learned from Drosophila models of Parkinson's disease?
    Guo M
    Prog Brain Res; 2010; 184():3-16. PubMed ID: 20887867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic mutations linked to Parkinson's disease differentially control nucleolar activity in pre-symptomatic mouse models.
    Evsyukov V; Domanskyi A; Bierhoff H; Gispert S; Mustafa R; Schlaudraff F; Liss B; Parlato R
    Dis Model Mech; 2017 May; 10(5):633-643. PubMed ID: 28360124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of Parkinson's disease-associated genes in mice reveals altered survival and bioenergetics of Parkin-deficient dopamine neurons.
    Giguère N; Pacelli C; Saumure C; Bourque MJ; Matheoud D; Levesque D; Slack RS; Park DS; Trudeau LÉ
    J Biol Chem; 2018 Jun; 293(25):9580-9593. PubMed ID: 29700116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orchestrated increase of dopamine and PARK mRNAs but not miR-133b in dopamine neurons in Parkinson's disease.
    Schlaudraff F; Gründemann J; Fauler M; Dragicevic E; Hardy J; Liss B
    Neurobiol Aging; 2014 Oct; 35(10):2302-15. PubMed ID: 24742361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auxilin Underlies Progressive Locomotor Deficits and Dopaminergic Neuron Loss in a Drosophila Model of Parkinson's Disease.
    Song L; He Y; Ou J; Zhao Y; Li R; Cheng J; Lin CH; Ho MS
    Cell Rep; 2017 Jan; 18(5):1132-1143. PubMed ID: 28147270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.
    Yasuda T; Mochizuki H
    Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease: a genetic perspective.
    Belin AC; Westerlund M
    FEBS J; 2008 Apr; 275(7):1377-1383. PubMed ID: 18279377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein.
    Lu XH; Fleming SM; Meurers B; Ackerson LC; Mortazavi F; Lo V; Hernandez D; Sulzer D; Jackson GR; Maidment NT; Chesselet MF; Yang XW
    J Neurosci; 2009 Feb; 29(7):1962-76. PubMed ID: 19228951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkin and defective ubiquitination in Parkinson's disease.
    Dawson TM
    J Neural Transm Suppl; 2006; (70):209-13. PubMed ID: 17017531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Drosophila model of Parkinson's disease.
    Feany MB; Bender WW
    Nature; 2000 Mar; 404(6776):394-8. PubMed ID: 10746727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What genetics tells us about the causes and mechanisms of Parkinson's disease.
    Corti O; Lesage S; Brice A
    Physiol Rev; 2011 Oct; 91(4):1161-218. PubMed ID: 22013209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Dopaminergic Functions in Drosophila.
    Inoshita T; Takemoto D; Imai Y
    Methods Mol Biol; 2021; 2322():185-193. PubMed ID: 34043204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potential therapeutic compounds for Parkinson's disease using Drosophila and human cell models.
    Sanz FJ; Solana-Manrique C; Muñoz-Soriano V; Calap-Quintana P; Moltó MD; Paricio N
    Free Radic Biol Med; 2017 Jul; 108():683-691. PubMed ID: 28455141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.